Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

170 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Primary IgA Vasculitis with Nephritis in a Patient with Rheumatoid Arthritis Diagnosed by Anti-galactose-deficient IgA1 Immunostaining.
Karasawa K, Iwabuchi Y, Kyoda M, Akihisa T, Yamaguchi E, Suzuki S, Ogura S, Takabe T, Miyabe Y, Kamiyama T, Nakano M, Manabe S, Kamiyama M, Akiyama K, Sato M, Uchida K, Nitta K, Moriyama T. Karasawa K, et al. Among authors: takabe t. Intern Med. 2019 Sep 1;58(17):2551-2554. doi: 10.2169/internalmedicine.2640-19. Epub 2019 Jun 7. Intern Med. 2019. PMID: 31178497 Free PMC article.
Long-term follow-up characteristics of patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) receiving chronic hemodialysis at a single center.
Miyabe Y, Karasawa K, Takabe T, Ogura S, Sugiura N, Kyoda M, Ono W, Akiyama K, Tanaka N, Moriyama T, Hanafusa N, Uchida K, Tuchiya K, Nitta K. Miyabe Y, et al. Among authors: takabe t. Clin Exp Nephrol. 2020 Feb;24(2):136-142. doi: 10.1007/s10157-019-01799-2. Epub 2019 Oct 22. Clin Exp Nephrol. 2020. PMID: 31641958
Successful Treatment with Belimumab in a Patient with Refractory Systemic Lupus Erythematosus after Initiation of Hemodialysis: Considering the Synergistic Effect of Belimumab and Immunological Burn-Out Phenomenon in End-Stage Renal Disease Patients on Hemodialysis.
Karasawa K, Ogura S, Takabe T, Miyabe Y, Iwabuchi Y, Akiyama K, Sato M, Moriyama T, Uchida K, Nitta K. Karasawa K, et al. Among authors: takabe t. Blood Purif. 2022;51(2):182-188. doi: 10.1159/000512585. Epub 2021 Apr 23. Blood Purif. 2022. PMID: 33895749
Recent Advances in Treatment Strategies for Lupus Nephritis.
Karasawa K, Uchida K, Takabe T, Moriyama T, Nitta K. Karasawa K, et al. Among authors: takabe t. Contrib Nephrol. 2018;195:42-50. doi: 10.1159/000486933. Epub 2018 May 7. Contrib Nephrol. 2018. PMID: 29734149 Review.
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study.
Piccini JP, Caso V, Connolly SJ, Fox KAA, Oldgren J, Jones WS, Gorog DA, Durdil V, Viethen T, Neumann C, Mundl H, Patel MR; PACIFIC-AF Investigators. Piccini JP, et al. Lancet. 2022 Apr 9;399(10333):1383-1390. doi: 10.1016/S0140-6736(22)00456-1. Epub 2022 Apr 3. Lancet. 2022. PMID: 35385695 Clinical Trial.
Evaluation of the Effect of Topiroxostat on Renal Function in Patients with Hyperuricemia: STOP-C Study, a Retrospective Observational Cohort Study.
Tamiya E, Yamashita H, Takabe T, Matsumoto T, Kajihara J, Yamamoto S, Kanoh T, Koide H, Minamino T. Tamiya E, et al. Among authors: takabe t. Drugs Real World Outcomes. 2022 Jun;9(2):299-306. doi: 10.1007/s40801-022-00291-w. Epub 2022 Jan 29. Drugs Real World Outcomes. 2022. PMID: 35094305 Free PMC article.
170 results